Metatissue received the SeloID from ANI

Metatissue received the “SeloID: Reconhecimento de idoneidade para a prática de atividades de I&D” from ANI – Agência Nacional de Inovação which certifies its competences in carrying out R&D activities in the areas of biotechnology and health.

This recognition obtained in May 2022 is valid for a period of 8 years, allowing Metatissue to be highlighted when compared to other companies in the national biotech applied to healthcare sector, being an important factor of differentiation and valorization, proving the necessary competence to carry out R&D activities.

From now on, Metatissue is considered as a preferred solution in projects submitted to SIFIDEII, guaranteeing that fees related to the provision of services involving R&D activities are eligible within the scope of application.